Find clinical trials for Melanoma in Chicago, IL
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Melanoma trials near Chicago, IL, USA:
binimetinib, and pembrolizumab) given together for the treatment of melanoma that:* is advanced or metastatic (spread to other parts of the ...
Phase 3
Park Ridge, Illinois, United States and 227 other locations
alone in participants with untreated, unresectable or metastatic melanoma. Participants randomized to the pembrolizumab monotherapy arm who ...
Phase 3
Chicago, Illinois, United States and 70 other locations
The study is focused on patients with a type of skin cancer known as melanoma. The aim of the study is to see how safe and effective the com...
Phase 3
Park Ridge, Illinois, United States and 75 other locations
efficacy of belzupacap sarotalocan (bel-sar) compared to sham control in patients with primary indeterminate lesions (IL) or small choroidal melanoma...
Phase 3
Chicago, Illinois, United States and 54 other locations
To evaluate the overall survival of HLA-A\*0201 positive adult patients with previously untreated advanced UM receiving IMCgp100 compared to Investig...
Phase 2
Chicago, Illinois, United States and 56 other locations
use the immune system to recognize and kill cancer cells. The study is focused on participants with a type of skin cancer known as melanoma...
Phase 2
Evanston, Illinois, United States and 44 other locations
A Phase 2 study to investigate the efficacy and safety of lerapolturev alone or in combination with a programmed death receptor-1 (anti-PD-1) inhibit...
Phase 2
Chicago, Illinois, United States and 11 other locations
treatment (pembrolizumab) in participants with advanced melanoma.The study will involve initial administration of EDP1503 for a run-in perio...
Phase 2
Chicago, Illinois, United States
treatment of adult subjects with completely treated high-risk ocular melanoma, as defined in eligibility criteria, without evidence of metas...
Phase 2
Chicago, Illinois, United States and 5 other locations
of nivolumab and ipilimumab in patients with metastatic uveal melanoma who have not been treated with immune checkpoint inhibitor therapy....
Phase 2, Phase 3
Chicago, Illinois, United States and 14 other locations
Clinical trials
Research sites
Resources
Legal